A large market for Cash Price Medications is, believe it or not, is scrips by Veterinarians. For the most part domestic animals are not covered by drug plans. The issue is that some pharmacies do not have the licenses required by states for filling vet scrips (last I checked C...

We do plan to expand into Vet Med as we expand our partner pharmacy network. Currently in process of integrating our network with one of the largest pharmacy chain in the country which would offer the capability to cover Vet Med. Other bolt-on lines include DME (Glucose monitor, etc) and labs. We plan to utilize our physician network, residency programs, medical podcasts, and medical influencers for our first phase of outreach depending on available funding. We expect to reach 5k prescribers ...

Just reviewed your market comp comp landscape vs iPrescribe and others.. so is it your intention to compete on price point basically at 1/3 the cost ? Why do that.. since you have a technical and partnership model advantage at play as well.. if you look at the user base of iPr...

Most of our cost is going to R&D, legal, and Medi-span integration. Our CAC is actually very low since we are utilizing our physician networks and we plan to offer both B2C (iPrescribe) and B2B (surescripts). There are quite a lot of info that we are not sharing with public and believe we have some unique angles for GTM as we understand physician pain points better than most. What's your email?

How do you see GoodRx? Competitor or collaborator? Are you looking to integrate GoodRx discounts into your app? Given the huge number of cash scripts leveraging GoodRx discounts, I'm trying to assess the potential/impact.

Hi Lance, Yes we are aware of goodrx and we have signed a co-marketing/revenue generating agreement with SingleCare recently (One of GoodRx's competitor). Our partnership with SingleCare allows us to offer extensive cash price drug options and nationwide pharmacy including CVS, Walmart, Walgreens. Our initial revenue generating model will come from per script utilizing Rx coupon and at scale will be Pharma advertisement. Looking forward to have you onboard!

eNavvi Updates, Team, and Funding Progress | Wefunder, Home of the Community Round

Voice Rx Assistant using eNavvi Intelligence (AI), to launch Oct 2024.

Agreement reached with PBM RXSense for transaction fees, expanding to 35,000 pharmacies in Sept 2024

Reached agreement with XPC Clinic for testing eNavvi Enterprise MVP in July 2024

Expanded Partnership with Cost Plus Drug Company to access 4000+ retail pharmacies in April 2024

Partnered with Wolters Kluwer (UpToDate) to incorporate MediSpan data in January 2024

Wilson Sonsini was appointed as eNavvi’s legal representation in November 2023

eNavvi reached agreement with BlueBerry Pharmacy and DiRX to accept prescriptions in May 2023

eNavvi signed a Co-Marketing Agreement with Cost Plus Drug Company in April 2023

eNavvi

eNavvi is an ePrescribing platform for physicians specializing in Cash Price Medications

$75,555

Updates

eNavvi

Quick facts

Team profiles

Featured investor profiles

$75,555

Updates